The use of hormonal contraceptives in fertility treatments: a committee opinion

Fertility and sterility · 2024 · vol. 122(2) , pp. 243–250 · doi:10.1016/j.fertnstert.2024.02.032 · PMID:38483428 · W4392768701
review OA: bronze CC0
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This committee opinion outlines the role and recommendations for using hormonal contraceptives in the context of fertility treatments.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The use of hormonal contraception can be considered to aid in the timing of assisted reproductive technology cycles, reduce the risk of ovarian cysts at in vitro fertilization cycle initiation, and optimize visualization before hysteroscopy.

My notes (saved in your browser only)

Funding

funders
[{'doi': '10.13039/100002603', 'name': 'American Society for Reproductive Medicine', 'awards': []}]

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Source provenance

crossref
last seen: 2026-08-14T06:25:22.657995+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK